Search - tctmd.com

Displaying 181 - 200 of 538

Sort: Relevancy | Date

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presentation EuroPCR 2017

A Prospective, Randomised Investigation of a Novel Transcatheter Aortic Valve Implantation System: The REPRISE III Trial

Presenter: Ted E. Feldman

May 16, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

May 12, 2017

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

May 02, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

March 24, 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

Live From Washington: ACC 2017, Day One

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

March 17, 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

March 17, 2017

Boston Scientific Recalls All Lotus Valves, Including Lotus with Depth Guard

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

Lotus TAVR Device with Depth Guard Reduces Risk of Pacemaker Implantation

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Early Clinical Outcomes with Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

January 25, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Daily News

Transcatheter Valve-in-Ring for Failed Tricuspid Repair: New Hope for Patients With Few Options

January 05, 2017

Transcatheter Valve-in-Ring Implantation for Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair

Presentation

Transcatheter Valve-in-Ring Implantation for Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair

Presenter: J. Aboulhosn

January 05, 2017

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

December 26, 2016

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

November 08, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.